Actively Recruiting
Establishing the Clinical Significance Values of the Lysholm Knee Score
Led by Kırklareli University · Updated on 2026-01-30
69
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
Sponsors
K
Kırklareli University
Lead Sponsor
G
Gazi University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to learn about patients who will undergo anterior cruciate ligament reconstruction. The main questions it aims to answer are: * What is the minimal clinically important difference value of the Lysholm Knee Score? * What is the substantial clinical benefit value of the Lysholm Knee Score? * What are the risk factors that prevent patients who have undergone anterior cruciate ligament reconstruction from reaching the minimal clinically important difference value? * What are the risk factors that prevent patients who have undergone anterior cruciate ligament reconstruction from reaching the substantial clinical benefit value?
CONDITIONS
Official Title
Establishing the Clinical Significance Values of the Lysholm Knee Score
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be over 18 years old
- Have a torn anterior cruciate ligament and plan to undergo surgery for it
You will not qualify if you...
- Have metabolic or autoimmune diseases
- Have had revision ACL surgery or ACL repair
- Have cognitive issues that prevent completing study forms
- Do not have sufficient proficiency in Turkish
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gazi Üniversitesi Hastanesi
Ankara, Turkey (Türkiye), 06490
Actively Recruiting
Research Team
O
Ozan Gür, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here